- Home
- IQV vs XYL Comparison
IQV vs XYL Comparison
Compare IQV & XYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- XYL
- Stock Information
- Founded
- IQV 1982
- XYL 2011
- Country
- IQV United States
- XYL United States
- Employees
- IQV N/A
- XYL N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- XYL Fluid Controls
- Sector
- IQV Health Care
- XYL Industrials
- Exchange
- IQV Nasdaq
- XYL Nasdaq
- Market Cap
- IQV 37.2B
- XYL 34.2B
- IPO Year
- IQV 2013
- XYL N/A
- Fundamental
- Price
- IQV $216.46
- XYL $150.85
- Analyst Decision
- IQV Strong Buy
- XYL Buy
- Analyst Count
- IQV 20
- XYL 10
- Target Price
- IQV $242.10
- XYL $160.00
- AVG Volume (30 Days)
- IQV 1.7M
- XYL 1.2M
- Earning Date
- IQV 10-28-2025
- XYL 10-28-2025
- Dividend Yield
- IQV N/A
- XYL 1.06%
- EPS Growth
- IQV N/A
- XYL 13.52
- EPS
- IQV 7.30
- XYL 3.88
- Revenue
- IQV $15,904,000,000.00
- XYL $8,894,000,000.00
- Revenue This Year
- IQV $6.01
- XYL $5.59
- Revenue Next Year
- IQV $4.87
- XYL $5.29
- P/E Ratio
- IQV $29.64
- XYL $38.89
- Revenue Growth
- IQV 3.85
- XYL 5.58
- 52 Week Low
- IQV $134.65
- XYL $100.48
- 52 Week High
- IQV $225.91
- XYL $154.27
- Technical
- Relative Strength Index (RSI)
- IQV 63.90
- XYL 61.52
- Support Level
- IQV $209.46
- XYL $146.46
- Resistance Level
- IQV $222.59
- XYL $154.27
- Average True Range (ATR)
- IQV 5.99
- XYL 2.61
- MACD
- IQV -0.12
- XYL 0.33
- Stochastic Oscillator
- IQV 65.80
- XYL 67.92
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About XYL Xylem Inc. New
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.